Last reviewed · How we verify

NCT06944847: VASP-S

Vaping and Smoking Project in People With Schizophrenia

Recruiting now NA Last updated 9 March 2026
What this trial tests

NA trial testing Acute (24-hour) abstinence in Acute Abstinence From Cigarettes vs E-cigarettes (ENDS) in 64 participants. Currently enrolling.

Timeline
15 February 2025
Primary endpoint
1 April 2027
1 April 2027

Quick facts

Lead sponsorState University of New York at Buffalo
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposebasic science
Enrollment64
Start date15 February 2025
Primary completion1 April 2027
Estimated completion1 April 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

State University of New York at Buffalo

Who can join

Adults 21 to 50, any sex, with Acute Abstinence From Cigarettes vs E-cigarettes (ENDS). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The proposed research will characterize withdrawal among people with schizophrenia who vape daily compared to people with schizophrenia who smoke combustible cigarettes daily, filling critical gaps in the understanding of electronic nicotine delivery systems (ENDS) dependence and contributing to the development of vaping cessation interventions amongst people with schizophrenia, the leading preventable cause of death in the US.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Acute (24-hour) abstinence

Trials testing the same drug.

Other recruiting trials for Acute Abstinence From Cigarettes vs E-cigarettes (ENDS)

Currently open trials in the same condition.

Other State University of New York at Buffalo trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06944847.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing